Centre for Endocrine and Diabetes Sciences, Department of Medicine, Cardiff University School of Medicine, Cardiff, UK
Search for other papers by Peter Taylor in
Google Scholar
PubMed
Search for other papers by Sandip Bhatt in
Google Scholar
PubMed
Search for other papers by Ravi Gouni in
Google Scholar
PubMed
Search for other papers by Jonathan Quinlan in
Google Scholar
PubMed
Search for other papers by Tony Robinson in
Google Scholar
PubMed
What Is Known about This Topic • The prevalence of hyperthyroidism in pregnancy has been estimated to range between 0.1 and 1% [ 1 , 2 , 3 , 4 , 5 ] and if untreated or poorly treated there is an increased risk of adverse outcomes including
Search for other papers by Hiroki Kobayashi in
Google Scholar
PubMed
Search for other papers by Akira Haketa in
Google Scholar
PubMed
Search for other papers by Masanori Abe in
Google Scholar
PubMed
Search for other papers by Kazunobu Tahira in
Google Scholar
PubMed
Search for other papers by Yoshinari Hatanaka in
Google Scholar
PubMed
Search for other papers by Sho Tanaka in
Google Scholar
PubMed
Search for other papers by Takahiro Ueno in
Google Scholar
PubMed
Search for other papers by Masayoshi Soma in
Google Scholar
PubMed
atrial tachycardia, atrial fibrillation (AF), and atrial flutter. Among these arrhythmias, AF is the most common, occurring in 9-22% of patients with hyperthyroidism [ 2 ]. Complications of AF in patients with hyperthyroidism include heart failure and
supported by endocrine physicians as well as the nuclear medicine departments of German university hospitals. In one such investigation, he demonstrated that relapsing Graves' hyperthyroidism can neither be predicted by the TRAb titre at the end of
Department of Radiology, Jichi Medical University, School of Medicine, Shimotsuke, Tochigi, Japan
Search for other papers by Tomohiro Kikuchi in
Google Scholar
PubMed
Search for other papers by Shouhei Hanaoka in
Google Scholar
PubMed
Search for other papers by Takahiro Nakao in
Google Scholar
PubMed
Center for Frontier Medical Engineering, Chiba University, Yayoicho, Inage–ku, Chiba, Japan
Search for other papers by Yukihiro Nomura in
Google Scholar
PubMed
Search for other papers by Takeharu Yoshikawa in
Google Scholar
PubMed
Search for other papers by Ashraful Alam in
Google Scholar
PubMed
Search for other papers by Harushi Mori in
Google Scholar
PubMed
Search for other papers by Naoto Hayashi in
Google Scholar
PubMed
. The PET images were acquired with the following parameters: FOV, 700 mm; matrix size, 128 × 128; voxel size, 5.47 × 5.47 × 3.25 mm. Hypothyroidism and hyperthyroidism, defined as elevated and decreased thyroid-stimulating hormone (TSH) levels
Search for other papers by Stefan Matei Constantinescu in
Google Scholar
PubMed
Search for other papers by Julien Hospel in
Google Scholar
PubMed
Search for other papers by Chantal Daumerie in
Google Scholar
PubMed
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
Search for other papers by Maria-Cristina Burlacu in
Google Scholar
PubMed
Introduction Graves’ disease (GD) is the most common cause of hyperthyroidism worldwide, with a cumulative lifetime risk of 3% in women and 0.5% in men ( 1 ). The disease is characterized by the presence of thyrotropin receptor
Search for other papers by Dominik Spira in
Google Scholar
PubMed
Search for other papers by Nikolaus Buchmann in
Google Scholar
PubMed
German Centre for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany
Search for other papers by Marcus Dörr in
Google Scholar
PubMed
German Centre for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany
Search for other papers by Marcello R P Markus in
Google Scholar
PubMed
Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany
Search for other papers by Matthias Nauck in
Google Scholar
PubMed
Search for other papers by Sabine Schipf in
Google Scholar
PubMed
Search for other papers by Joachim Spranger in
Google Scholar
PubMed
Charité – Universitätsmedizin Berlin, BCRT – Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany
Search for other papers by Ilja Demuth in
Google Scholar
PubMed
Search for other papers by Elisabeth Steinhagen-Thiessen in
Google Scholar
PubMed
Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
Search for other papers by Henry Völzke in
Google Scholar
PubMed
Search for other papers by Till Ittermann in
Google Scholar
PubMed
hyper- and hypothyroidism. Mechanisms included in hyperthyroidism are an increased hepatic glucose output through a higher rate of gluconeogenesis and glycogenolysis induced by thyroid hormones. Usually, hyperthyroidism also leads to an increased glucose
Search for other papers by Jun Yang in
Google Scholar
PubMed
Search for other papers by Meng-Jie Dong in
Google Scholar
PubMed
Search for other papers by Qin Xu in
Google Scholar
PubMed
and high rate of recurrence. A 53-year-old Chinese man was admitted to our hospital in December 2012 because he presented a 14-year history of uncontrolled hyperthyroidism. The exophthalmos and dermopathy were not observed. The patient does not
Search for other papers by Tanja Diana in
Google Scholar
PubMed
Search for other papers by Christian Wüster in
Google Scholar
PubMed
Search for other papers by Paul D. Olivo in
Google Scholar
PubMed
Search for other papers by Angelica Unterrainer in
Google Scholar
PubMed
Search for other papers by Jochem König in
Google Scholar
PubMed
Search for other papers by Michael Kanitz in
Google Scholar
PubMed
Search for other papers by Artur Bossowski in
Google Scholar
PubMed
Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
Search for other papers by George J. Kahaly in
Google Scholar
PubMed
p ≤ 0.05. Results The demographic and serological data of all 40 investigated patients with AITD are summarized in Table 1 . Thirty well-characterized, untreated, hyperthyroid TSAb-positive/TBAb-negative patients with GD were included as
Department of Clinical Sciences, Lund University, Lund
Search for other papers by Mikael Lantz in
Google Scholar
PubMed
Search for other papers by Jan Calissendorff in
Google Scholar
PubMed
Search for other papers by Frank Träisk in
Google Scholar
PubMed
Search for other papers by Leif Tallstedt in
Google Scholar
PubMed
Department of Clinical Sciences, Lund University, Lund
Search for other papers by Tereza Planck in
Google Scholar
PubMed
Search for other papers by Ove Törring in
Google Scholar
PubMed
Department of Clinical Sciences, Lund University, Lund
Search for other papers by Bengt Hallengren in
Google Scholar
PubMed
Department of Clinical Sciences, Lund University, Lund
Search for other papers by Peter Åsman in
Google Scholar
PubMed
knowledge about retrobulbar morphological changes in patients with Graves' hyperthyroidism without clinical ophthalmopathy, it may be of importance to intervene as early as possible. The aim of this trial was to investigate if adjuvant treatment of GD, with
Search for other papers by Annelies Tonnelier in
Google Scholar
PubMed
Search for other papers by Jeroen de Filette in
Google Scholar
PubMed
Search for other papers by Ann De Becker in
Google Scholar
PubMed
Search for other papers by Sophie Deweer in
Google Scholar
PubMed
Search for other papers by Brigitte Velkeniers in
Google Scholar
PubMed
stimulating hormone (TSH), elevated free thyroxine (fT4), and elevated free triiodothyronine (fT3) levels, in particular, with or without symptoms of hyperthyroidism. A further distinction between the 2 types is made based on the presence of thyroid antibodies